Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

Subjects:

Pooled effect of the therapeutic effects of negative pressure wound therapy versus conventional wound care for sternal wound infection. by Si He (3236646)

Subjects:

Forest plots of secondary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. by Si He (3236646)

Subjects:

Study flow chart. by Karl Ingard (22582091)

Subjects:

Extracted data and used for analysis. by Si He (3236646)

Subjects:

Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

Subjects:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. by Karl Ingard (22582091)

Subjects:

Excluded studies with reasons for exclusion. by Si He (3236646)

Subjects:

Subgroup Analysis of the Occurrence of the Primary Endpoint and Its Components. by Karl Ingard (22582091)

Subjects:

Flow diagram of the studies included in the meta-analysis. by Si He (3236646)

Subjects:

Soil organic carbon (SOC) content in different land use types (a) and different soil types (b). by Kai Liu (159026)

Subjects:

Table 1_Biochar-based fertilizer increases soil nutrients and enhances tea quality: a metabolomics-based analysis.docx by Zhenyu Yang (427524)

“…</p>Results<p>Results showed that BF application significantly increased soil pH and nutrient availability, as well as the bud length and hundred-bud weight (p < 0.05). …”

Cinnamaldehyde repellency test within 6 hours in parthenogenesis <i>H. longicornis.</i> by Ceyan Kuang (8554557)

Subjects:

Interactive geographical detection results during 2011–2022: (a1) Soil erosion area in 2011; (a2) Soil erosion area in 2022; (a3) Changes of soil erosion area in 12 years; (b1) Soi... by Zhijia Gu (9274634)

Subjects:

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”

Comparison of 1^st, 2^nd, and 3^rd antibiotic prescription. by Thomas Hanslmeier (19949694)

Subjects: “…fluoroquinolone shares decreased…”